Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1998-11-12
pubmed:abstractText
DNA polymerase beta (pol beta) is the most error prone of all known eukaryotic DNA polymerases tested in vitro. Here, we show that cells overexpressing pol beta cDNA have acquired a spontaneous mutator phenotype. By measuring the appearance of mutational events using three independent assays, we found that genetic instability increased in the cell lines that overexpressed pol beta. In addition, these cells displayed a decreased sensitivity to cancer chemotherapeutic, bifunctional, DNA-damaging agents such as cisplatin, melphalan, and mechlorethamine, resulting in enhanced mutagenesis compared with control cells. By using cell-free extracts and modified DNA substrates, we present data in support of error-prone translesion replication as one of the key determinants of tolerance phenotype. These results have implications for the potential role of pol beta overexpression in cancer predisposition and tumor progression during chemotherapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-1738180, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-2039987, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-2698255, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-2710127, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-3988773, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-4682600, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-7628020, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-7777511, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-7997877, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8012973, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8538772, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8663082, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8674066, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8943009, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-8988050, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-9038207, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-9288785, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-9360635, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-9390556, http://linkedlifedata.com/resource/pubmed/commentcorrection/9770529-9521327
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
12586-90
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.
pubmed:affiliation
Institut de Pharmacologie et Biologie Structurale, Unité Propre de Recherche Centre National de la Recherche Scientifique 9062, 31077 Toulouse cédex, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't